Genoveffa Franchini
10Patents
5h-index
26Co-inventors
66Inventor score
Filing activity: Mar 31, 1989 → Oct 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6596279B1 | Immunodeficiency recombinant poxvirus | Chemistry; Metallurgy | 34 | Expired |
| US5420030A | Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5576000A | Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and uses thereof | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5223423A | Characterization of replication competent human immunodeficiency type 2 proviral clone HIV-2.sub.SBL/ISY | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7094408B2 | Immunogenicity using a combination of DNA and vaccinia virus vector vaccines | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7790182B2 | Protein vaccines against poxviruses | Chemistry; Metallurgy | 5 | Active |
| US5869313A | Molecular clones of HIV-1 viral strains MN-ST1 and BA-L, and uses thereof | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7771729B2 | Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12162910B2 | Recombinant gp120 protein with V1-loop deletion | Physics | 0 | Active |
| US10398772B2 | Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.